Boivin Lab

Boivin Lab

Ben Boivin Research Team

 

Redox Biology and Signal Transduction Laboratory

Cells have evolved ways of responding to complex cues from their environment. Our research group explores how these cues are integrated and controlled within cells. More precisely, our work focuses on how the redox modification of proteins, in particular protein tyrosine phosphatases (PTPs), influence phosphorylation-dependent signal transduction in biology and pathologies. 

We tackle this fundamental aspect of cell signaling using complementary approaches that broadly fall into two categories. One, we employ animal and cellular models jointly with screening methods to gain knowledge from complex systems and identify components that are dysregulated in disease states. Two, we build on knowledge acquired from both the literature and our own work to perform structure-function studies. 

Such studies help us understand how redox post-translational modifications of specific proteins cause structural changes that will in turn affect their enzymatic activity, protein-protein interactions and cellular function. Hence, while deciphering redox-regulated signaling networks and identifying unique signaling nodes are important initially in understanding a disease state, our structure-function approach generates critical mechanistic insight that allows us to target signaling nodes in complex pathologies. 

Overall, we study how cellular oxidants regulate phosphorylation-dependent signaling in cancer and in cardiovascular pathologies with the ultimate goal of developing strategies and technologies to restore physiological response.

Research

 

“We want to understand the function and the regulation of the protein tyrosine phosphatase family members in diseases such as cardiac hypertrophy, diabetes and cancer with the ultimate goal of activating or inhibiting specific PTPs to prevent or cure these diseases.”

- Ben Boivin, Director of the Redox Biology and Signal Transduction Laboratory

Projects:

  1. Understanding the oxidation mechanisms that control protein tyrosine phosphatase activity in vivo
  2. Allosteric-site mediated activation of protein tyrosine phosphatase
  3. Understanding the molecular function of PTP1B in cardiac hypertrophy
  4. Understanding the molecular function of PTPs in insulin resistance
  5. Understanding the function of cholesterol in redox signaling

People

Director

Ben Boivin

Ben Boivin
Associate Professor
CNSE’s Department of Nanoscale Science & Engineering and CAS’s Department of Biological Sciences
[email protected]
Life Sciences Research Building
Lab: Room 1153
Office: Room 1147
518-437-4464

Ben earned his BS and PhD degrees in biochemistry from the University of Montreal. After completing his PhD at the Montreal Heart Institute by working on nuclear G-protein coupled receptors in the heart, he joined the Cold Spring Harbor Laboratory for postdoctoral training on the redox-regulation of protein tyrosine phosphatases (PTP). The current focus of his lab is to understand how cells respond to their environment by sending intracellular redox signals that turn off PTPs and regulate phosphorylation events. Researchers concentrate their efforts on understanding how PTPs can be reactivated in vitro and in vivo and how they can reestablish physiological signaling. Ben’s research has been acknowledged by fellowships, scholarships and awards and his lab is funded by the National Institutes of Health.


PhD Students

Soumi Naskar.

Soumi Naskar
(Since 2025)
[email protected]

Soumi is pursuing a PhD in biology with a focus on redox mechanisms that regulate PTPs in the heart. She works on identifying enzyme complexes and delineating pathways that inactivate PTPs in the heart to find novel approaches to reestablish physiological signaling in cardiac hypertrophy. She joined the lab after working in R&D at Enzene Biosciences. She holds a master’s in pharmaceutical biotechnology that focused on the osteoprotective activity of different Tinospora species (Bharati Vidyapeeth Deemed University) and a bachelor’s in pharmaceutical technology (Maulana Abul Kalam Azad University).


John Pareis.

John Pareis
(Since 2023)
[email protected]

John is pursuing a PhD in nanobioscience after earning a BS in nanoscale science (SUNY Polytechnic Institute). He’s interested in understanding how cholesterol interacts with a wide range of proteins in cells and how it affects their redox status. The goal of understanding this phenomenon is to eventually design small molecules that can allosterically reduce proteins to modify their catalytic activity.


Postdoctoral Researchers

Sanjukta Guha

Sanjukta Guha
(Since 2024)
[email protected]

Sanjukta’s research focuses on understanding the role of redox signaling in disease initiation and progression with a particular emphasis on investigating the in vivo oxidation of protein tyrosine phosphatases (PTPs). She aims to develop therapeutic strategies to restore PTP activity and normalize tyrosine-dependent signaling, with the goal of suppressing tumor growth and advancing cancer treatment. Sanjukta holds a PhD in cell/cellular and molecular biology from the LV Prasad Eye Institute, where she investigated the role of oxidative stress in congenital hereditary endothelial dystrophy. She also holds an MS in molecular biology (West Bengal University of Technology) and a BS in botany (University of Calcutta). 


Shweta Malik.

Shweta Malik 
(Since 2025)
[email protected]

Shweta is interested in understanding the molecular mechanisms controlling PTP1B oxidation and downstream thyroid hormone signaling in cardiac hypertrophy. Her goal is to develop novel PTP1B-targeting peptides that destabilize the oxidized form of PTP1B and specifically activate the phosphatase in vivo as a potential therapeutic strategy. She holds a PhD in biotechnology (Central University of Rajasthan), a master’s in biotechnology (Amity University) and a bachelor’s in botany (University of Delhi). Her previous work focused on amyloid-like protein aggregates. 


Reddy Sudheer Sagabala.

Reddy Sudheer Sagabala
(Since 2024)
[email protected]

Reddy’s lab work revolves around the biochemical and biophysical characterization of mechanisms by which sterols can regulate protein tyrosine phosphatases in vitro, in cells and in vivo. He earned a PhD in nanoscale science at SUNY Polytechnic Institute, where he worked on the redox regulation of protein tyrosine phosphatases. He also holds both a master’s in bioinformatics and bachelor’s in biotechnology from Sri Venkateswara University. 


Alumni

Graduate students and postdoctoral researchers

William Mudd MS (2020-2023)
Avinash Londhe PhD (2016-2023)
Reddy Sudheer Sagabala PhD (2016-2022)
Stephanie Curley PhD (2018-2019)
John Woodward MS (2017-2019)
Syed Rizvi PhD (2016-2019)
Gérald Coulis PhD (2013-2018)
Alexandra Bergeron MS (2014-2016)
 

Selected Publications

Londhe AD, Boivin B. Measuring the Reversible Oxidation of Protein Tyrosine Phosphatases Using a Modified Cysteinyl-Labeling Assay. Methods Mol Biol. 2024;2743:223-37.

Coulis G, Londhe AD, Sagabala RS, Shi Y, Labbé DP, Bergeron A, Sahadevan P, Nawaito SA, Sahmi F, Josse M, Vinette V, Guertin MC, Karsenty G, Tremblay ML, Tardif JC, Allen BG, Boivin B. Protein tyrosine phosphatase 1B regulates miR-208b-argonaute 2 association and thyroid hormone responsiveness in cardiac hypertrophy. Sci Signal. 2022;15(730):eabn6875.

Londhe AD, Bergeron A, Curley SM, Zhang F, Rivera KD, Kannan A, Coulis G, Rizvi SHM, Kim SJ, Pappin DJ, Tonks NK, Linhardt RJ, Boivin BRegulation of PTP1B activation through disruption of redox-complex formation. Nat Chem Biol. 2020;16(2):122-125.

Yang M, Haase AD, Huang FK, Coulis G, Rivera KD, Dickinson BC, Chang CJ, Pappin DJ, Neubert TA, Hannon GJ, Boivin B, Tonks NK. Dephosphorylation of tyrosine 393 in argonaute 2 by protein tyrosine phosphatase 1B regulates gene silencing in oncogenic RAS-induced senescence. Mol Cell. 2014;55(5):782-90. Senior & Corresponding Author

Boivin B, Chaudhary F, Dickinson BC, Haque A, Pero SC, Chang CJ, Tonks NK. Receptor protein-tyrosine phosphatase α regulates focal adhesion kinase phosphorylation and ErbB2 oncoprotein-mediated mammary epithelial cell motility. J Biol Chem. 2013;288(52):36926-35.

Boivin B, Yang M, Tonks NK. Targeting the reversibly oxidized protein tyrosine phosphatase superfamily. Sci Signal. 2010 Aug 31;3(137):pl2. Review.

Boivin B, Zhang S, Arbiser JL, Zhang ZY, Tonks NK. A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells. Proc Natl Acad Sci USA. 2008;105(29):9959-64.

Complete List of Published Work in MyBibliography: https://www.ncbi.nlm.nih.gov/myncbi/1pkz7LaXyjq5c/bibliography/public/